Cardiac Neuromodulation Therapy – a novel device-based therapy for patients with hypertension and indications for pacing
 
More details
Hide details
1
1st Chair and Department of Cardiology, Medical University of Warsaw, Warszawa, Poland
2
Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center for Heart Diseases, Silesian Medical University, Zabrze, Poland
3
Department of Cardiology, Pomeranian Medical University, Szczecin, Poland
4
1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland
5
Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland
6
Department of Heart Arrhythmia, Institute of Cardiology, Warsaw, Poland
CORRESPONDING AUTHOR
Monika Cywińska   

1st Chair and Department of Cardiology, Medical University of Warsaw, Warszawa, Poland
Publication date: 2019-12-30
 
Heart Beat 2019;4:51–55
KEYWORDS
TOPICS
ABSTRACT
Cardiac Neuromodulation Therapy (CNT) is a novel device-based therapeutic method for reducing systolic blood pressure (SBP). It incorporates asymmetrical pacing algorithm with alternating shortened and prolonged atrioventricular intervals into existing pacemaker hardware. It has been developed to meet growing demand for non-pharmacological therapies for patients with resistant arterial hypertension (HTN) and indications for permanent pacing. In this article, we explain the mechanism of the programmable therapy and review current literature, including the most recent clinical trials.
eISSN:2543-6333